J.ophthalmol.(Ukraine).2022;4:3-11.

Pdf

http://doi.org/10.31288/oftalmolzh20224311 

Received: 20.06.2022; Accepted: 18.07.2022; Published on-line: 24.08.2022


Sensitivity of peripheral blood lymphocytes to adrenaline and acetylcholine in patients with primary and recurrent posterior uveitis 

N. I. Khramenko, L. M. Velychko, O. V. Bogdanova, N. V. Konovalova, Iu. O. Zhuravok 

SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine"

Odesa (Ukraine) 

TO CITE THIS ARTICLE: Khramenko NI, Velychko LM, Bogdanova OV, Konovalova NV, Zhuravok IuO. Sensitivity of peripheral blood lymphocytes to adrenaline and acetylcholine in patients with primary and recurrent posterior uveitis. J.ophthalmol.(Ukraine).2022;4:3-11.    http://doi.org/10.31288/oftalmolzh20224311

 

Background: Posterior uveitis is a polyetiologic group of diseases with polymorphic clinical manifestations and a prolonged, chronic and recurrent course. In addition, it is commonly bilateral and often causes complications, loss of working capacity and early visual disability in young adults. It is an important task of current clinical ophthalmology to find biomarkers indicating the severity of inflammation and the likelihood of developing a recurrence of the initial process.

Purpose: To determine the sensitivity of peripheral blood lymphocytes to adrenaline and acetylcholine in patients with primary and recurrent uveitis at different phases of the disease.

Material and Methods: One hundred patients with idiopathic posterior uveitis were examined at different phases of the disease. The control group was composed of 16 healthy individuals of a similar age. The specific sensitivity of lymphocytes to neuromediators, adrenaline and acetylcholine (expression of T cell adrenergic and acetylcholine receptors) was assessed using our complex methodology (in conjunction with a parallel sampling method) for assessing the individual’s sensitivity to medicaments (biological regulators) which has been developed at Immunology laboratory, Filatov Institute of Eye Disease and Tissue Therapy. The method involves obtaining lymphocytes from an individual, culturing lymphocytes with examined drugs immunohistochemically, and use of a peroxidase anti-peroxidase method with monoclonal T-cell antibodies.

Results: Absolute and relative adrenoreceptor and acetylcholine receptor expression levels in patients with posterior uveitis were 1.8-2.0 times and 1.6-2.4 times, respectively, higher in patients with posterior uveitis compared to controls. Absolute adrenoreceptor and acetylcholine receptor expression values were 12.6% and 31.7%, respectively, higher in the recurrent process during active inflammation compared to the period of remission. However, in patients with posterior uveitis, adrenoreceptor and acetylcholine receptor expression values in the period of remission were still higher than normal values. The odds of an increased relative adrenoreceptor expression and the odds of an increased relative acetylcholine receptor expression on peripheral blood lymphocytes were 67.5-fold higher and 23.6-fold higher, respectively, among patients with posterior uveitis compared to controls. The correlation of adrenoreceptor expression and acetylcholine receptor expression with absolute counts of T cells and T helpers was stronger than the correlation with B cells, which reflects to a larger extent the association with the cellular immunity and to a lesser extent the association with the humoral immunity. There was a moderate correlation of adrenoreceptor expression and acetylcholine receptor expression with cell subsets of markers of early lymphocyte activation CD5, autoimmune aggression CD25, intercellular adhesion CD54 and apoptosis CD95 (Fas/APO-1).

Conclusion: The adrenoreceptor expression and acetylcholine receptor expression on peripheral blood lymphocytes may be used as a non-specific biomarker of an activated inflammatory process in posterior uveitis.

Keywords: posterior uveitis, adrenaline, acetylcholine, lymphocyte activation biomarkers

 

References

1.Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science. 2012;335(6071):936-941.

Crossref 

2.Quatrini L, Vivier E, Ugolini S. Neuroendocrine regulation of innate lymphoid cells. Immunol Rev. 2018 Nov;286(1):120-36.

Crossref  PubMed

3.Capellino S, Claus M, Watzl C. Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine. Cellular & molecular immunology. 2020 Jul;17(7):705–11.

Crossref   PubMed

4.Tarr AJ, Powell ND, Reader BF, et al. beta‐Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption. Brain Behav Immun. 2012 Nov;26(8):1226-38.

Crossref   PubMed

5.Suzuki K, Hayano Y, Nakai A, Furuta F, Noda M. Adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodes. J Exp Med. 2016 Nov 14;213(12):2567-74.

Crossref   PubMed

6.Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004 Jul;130(4):601-30.

Crossref   PubMed

7.Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol. 2009 Feb;10(2):195-202.

Crossref   PubMed

8.Härle P, Straub RH, Wiest R, Mayer A, Schölmerich J, Atzeni F, et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis. 2006 Jan;65(1):51-6.

Crossref   PubMed

9.Ribeiro-da-Silva M, Vasconcelos DM, Alencastre IS, Oliveira MJ, Linhares D, Neves N, et al. Interplay between sympathetic nervous system and inflammation in aseptic loosening of hip joint replacement. Sci Rep. 2018 Oct 30;8(1):16044.

Crossref   PubMed

10.Khramenko NY, Ponomarchuk VS, Haydamaka TB, Drozhzhyna HY. [Features of the state of the autonomic nervous system and its influence on the regional hemodynamics of the eye in patients with different nature of the course of recurrent herpetic keratitis]. Oftalmol Zhurn. 2013;6:5-11.  Russian.

Crossref

11.KhramenkoN, Usov V, Velychko L, Konovalova N, Bogdanova O. Level of adrenoreception and acetylcholine reception on lymphocytes in peripheral blood in patients with anterior uveitis complicated by macular edema. DOG online. 2021. Abstract number A-1213-0052-00519.

12.Velychko L, Bogdanova O. Patent № 103483.[ A method for studying the receptor-modifying effect of pharmacological immunotropic drugs on markers of cell activation]. 2015, Bul No. 24. Ukrainian.

13.Dehtyarenko TV, Makulʹkyn RF. [Biogenic stimulants and immunoreactivity]. In 2 volumes, volume 2. Odessa: Mayak; 1997. Russian.

14.Hluzman DF, Sklyarenko LM, Nahornaya VA, Kryachok YA. [Diagnostic immunocytochemistry of tumors]. Kyiv:Morion; 2003. Russian

15.Litvinova LS, Gutsol AA, Sokhonevich NA, Kofanova KA, Khaziakhmatova OG, Shupletsova VV, et al. [Basic surface markers of functional activity T-limphocytes]. Medical Immunology. 2014;16(1):7-26. Russian.

Crossref

16.Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020 Sep;108(3):787-99.

Crossref   PubMed

17.Sakamoto T, Takahira K, Sanui H, Kohno T, Inomata H. Intercellular adhesion molecule-1 on rat corneal endothelium in experimental uveitis. Exp Eye Res. 1993 Feb;56(2):241-6.

Crossref   PubMed

18.Soldevila G, Raman C, Lozano F. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease. Curr Opin Immunol. 2011 Jun;23(3):310-8.

Crossref   PubMed

19.Sugita S, Taguchi C, Takase H, Sagawa K, Sueda J, Fukushi K, et al. Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis. Br J Ophthalmol. 2000 Oct;84(10):1130-4. Crossref   PubMed

20.Andersson U, Tracey KJ. Reflex principles of immunological homeostasis. Annu Rev Immunol. 2012;30:313-35.

Crossref   PubMed

21.Nourshargh, S, Alon R. Leukocyte migration into inflamed tissues. Immunity. 2014 Nov 20;41(5):694-707.

Crossref   PubMed

22.Mueller SN. Neural control of immune cell trafficking. J Exp Med. 2022 Mar 7;219(3):e20211604.

Crossref   PubMed

23.Kawashima K, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 2003 Dec 26;74(6):675-96.

Crossref   PubMed

24.Cox MA, Duncan GS, Lin GHY, Steinberg BE, Yu LX, Brenner D, et al. Choline acetyltransferase-expressing T cells are required to control chronic viral infection. Science. 2019 Feb 8;363(6427):639-44.

Crossref   PubMed

 

 

Disclosures 

Corresponding Author: Khramenko Nataliia, e-mail: khramenkon@gmail.com

Disclaimer: the opinions presented in the article are solely the author's, they do not represent the official position of the institution.

Sources of Support: There are no external sources of funding.

Conflict of Interest Statement. The authors certify that there is no conflict of interest that could influence their opinion regarding the subject matter or materials described and discussed in this article.